EFTA00314066.pdf

89/21/2018 18:18 From: Woodson C. Merrell M Ileac( Page: 11/13 gLabCorp Patient Report Specimen ID: 257480-2715-0 Control ID: END31143092 Aca 8: 31143092 Phonic Rex 68 EPSTEIN,JEFFREY Woodson Merrel 9E 715T ST 44 E 67th St NEW YORK NT 10021 NewYmkNY100l5 Patient Details Sperber Details DOS: 0t/20/1963 Plyddan Details Date collected: 09/14/2018 1255 Local Agely/m/d):065/07/25 OrderistrW MERRELL Date received: 09/15/2018 RaNning: Gender: M MN: Date enters* 09/15/2018 Patient Ilk ID: Date reports* 09/18/2018 0610 ET NPt 1023153509 General Comments & Additional Information Total Volume: Not Provided Faming: No Ordered Items Chlamydle/GC Amplification, Panel OR3014c, HCV Ab veRflx to Vertficaton; RPR, Rfx On RPR/Ccrtfirm TP RESULT FLAG UNITS REFERENCE INTERVAL Chlamydia/GC Amplification LAB Chlamydia trachomatis, NAA Negative Neisseria gonorthoeae, NAA Negative 01 Negative Negative 01 Panel 083935 HIV Screen 4th Generation wRfx Non Reactive Non Reactive 01 ACV Ab w/Rflx to Verification RCV Ab <0.1 s/co ratio 0.0 - 0.9 01 Comment: Non reactive HCV antibody 'Noreen is consistent 01 with no HCV infection, unless recent infection is suspected or other evide indicate MeV infection. nce exists to APR, Rix On APA/Confirm TP RPR Non Reactive Non Reactive 01 01 RN LabCorp Raritan Dr: fiscal B Rayea. MD 59 Fist Menus. Raritan. NJ 011a80-1000 For Meekest Se physiolan may contact Brands Dare issues: owl via IOU ET FINAL REPORT Bus document contains rate end colidential Mori Wormation rem toll you by sum an0 federal km. e199540111tabonearyCornamean of kwerla•Holdinv ffecttaxl this docufnont In 4100r, plan NIActa Sans • Enimixte leport fleflort 100 EFTA00314066